> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Assessing Drug User Fees
- URL: https://www.fdaweb.com/guide-on-assessing-drug-user-fees-2/
- Published: 2020-11-10T12:00:00.000Z
- Updated: 2026-09-14T16:35:51.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148047

*Federal Register* notice: FDA has made available a revised final guidance on “Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017.” The guidance supersedes the now withdrawn and same titled final guidance issued in 5/2018\. The revision removes Section VI.B. regarding the “same product as another product” prescription drug program fee exception for certain prescription drug products under the federal Food, Drug, and Cosmetic Act. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-11-10/pdf/2020-24941.pdf?ref=fdaweb.com).